These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8573751)

  • 21. Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats.
    Mifsud SA; Skinner SL; Cooper ME; Kelly DJ; Wilkinson-Berka JL
    J Am Soc Nephrol; 2002 Mar; 13(3):684-692. PubMed ID: 11856772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model.
    Dhein S; Hochreuther S; Aus Dem Spring C; Bollig K; Hufnagel C; Raschack M
    J Pharmacol Exp Ther; 2000 May; 293(2):351-9. PubMed ID: 10773002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
    Katoh M; Ohmachi Y; Kurosawa Y; Yoneda H; Tanaka N; Narita H
    Eur J Pharmacol; 2000 Jun; 398(3):381-7. PubMed ID: 10862828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
    Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
    Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perindopril attenuates tubular hypoxia and inflammation in an experimental model of diabetic nephropathy in transgenic Ren-2 rats.
    Wiggins KJ; Tiauw V; Zhang Y; Gilbert RE; Langham RG; Kelly DJ
    Nephrology (Carlton); 2008 Dec; 13(8):721-9. PubMed ID: 18826488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathy.
    Rumble JR; Gilbert RE; Cox A; Wu L; Cooper ME
    J Hypertens; 1998 Nov; 16(11):1603-9. PubMed ID: 9856360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes.
    Tikellis C; Brown R; Head GA; Cooper ME; Thomas MC
    Am J Physiol Renal Physiol; 2014 Apr; 306(7):F773-80. PubMed ID: 24477684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACE-inhibitor suppresses the apoptosis induced by endoplasmic reticulum stress in renal tubular in experimental diabetic rats.
    Sun HL; Sun L; Li YY; Shao MM; Cheng XY; Ge N; Lu JD; Li SM
    Exp Clin Endocrinol Diabetes; 2009 Jul; 117(7):336-44. PubMed ID: 19301230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of perindopril on the renal haemodynamic changes associated with adaptation to sodium restriction in the rat.
    Jover B; Dupont M; Mimran A
    J Hypertens Suppl; 1988 Dec; 6(3):S75-7. PubMed ID: 2852238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal angiotensin-converting enzyme localization in diabetic rats and the effect of low protein diet.
    Mizuiri S; Kobayashi M; Nakanishi T; Yoshikawa H; Miyagi M; Tanegashima M; Sakai K; Hayashi I; Fushimi T; Hasegawa A
    Nephron; 1997; 76(2):186-91. PubMed ID: 9200410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
    Sebeková K; Lill M; Boor P; Heidland A; Amann K
    Am J Nephrol; 2009; 29(3):164-70. PubMed ID: 18753741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
    Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
    J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.
    Duncan AM; Burrell LM; Kladis A; Campbell DJ
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):746-54. PubMed ID: 8961071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
    Motawi TK; El-Maraghy SA; Senousy MA
    J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and chronic effects of angiotensin-converting enzyme inhibitors on tissue angiotensin-converting enzyme.
    Chai SY; Perich R; Jackson B; Mendelsohn FA; Johnston CI
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():7-12. PubMed ID: 1327597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats.
    Hill C; Logan A; Smith C; Grønbaek H; Flyvbjerg A
    Diabetologia; 2001 Apr; 44(4):495-500. PubMed ID: 11357481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB; Black MJ; Bertram JF; Bobik A
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action.
    Cao Z; Hulthén UL; Allen TJ; Cooper ME
    J Hypertens; 1998 Jun; 16(6):793-9. PubMed ID: 9663919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
    Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Linz W; Schölkens BA; Wiemer G; Unger T
    Hypertension; 1993 Nov; 22(5):682-7. PubMed ID: 8225528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.